Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Oxis International completes phase I testing of IBD treatment

Jan. 8, 1997

Anti-HCV agents revealed by Japanese and Chinese investigators

Jan. 8, 1997

Prokinetic agents from Tokyo Tanabe

Jan. 8, 1997

Shin Nippon discloses antiulcer agents

Jan. 7, 1997

Lansoprazole equieffective to omeprazole in Dutch trial

Jan. 2, 1997

Novel human serine protease inhibitor for pancreatitis claimed by Incyte

Jan. 2, 1997

Additional filings and positive clinical results for Zadaxin

Dec. 23, 1996

Takeda claims new treatments for pancreatitis

Dec. 23, 1996

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Dec. 13, 1996

Roberts in-licenses another GI drug from Lilly

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...